|
|
HIV/AIDS Policy: Patents
- Brazil May Reject Gilead's AIDS Drug Patent (April 11, 2008)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Thai-Ing to Change the System (February 22, 2008)
U.S. advocates join call for Thailand to stand up to PhRMA and continue life-saving generic drug program.
In Housing Works AIDS Issues Update, from Housing Works
- Gilead Sciences May Lose Patent for Viread (January 25, 2008)
Looser patent laws could mean generic version of Tenofovir to come.
In Housing Works AIDS Issues Update, from Housing Works
- India's Decision to Adhere to International Patent Regulations Could Limit Access to Medicines, Including HIV/AIDS Drugs (January 8, 2007)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Developing Countries Should Use Trade Rules to Circumvent Patent Laws on AIDS Drugs, WHO Official Says (September 23, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Medical Innovation and Patent Gridlock (June 20, 2005)
John James with a different take on why patents tend to stifle innovation in drug development.
In AIDS Treatment News, from AIDS Treatment News
- Congress Should Vote Down CAFTA Because of Patent Protections on Drugs, Including Antiretrovirals, Opinion Piece Says (May 27, 2005)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Patent Primer (February 2002)
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Making Patents Public: Redefining Intellectual Property When AIDS Drugs Are at Issue (October 11, 2001)
From FindLaw.com
- Africa Access: Moving Fast, Outcome Uncertain (February 23, 2001)
In AIDS Treatment News, from AIDS Treatment News
- GATT and the Gap: How to Save Lives (November 20, 1998)
How the Global Agreement on Tariffs and Trade could affect treatment access in developing countries.
From AIDS Treatment News
|
|
